Safety of Selective COX‐2 Inhibitors in Aspirin/Nonsteroidal Anti‐inflammatory Drug‐Intolerant Patients: Comparison of Nimesulide, Meloxicam, and Rofecoxib

References

• Sanchez‐Borges M, Capriles‐Hulett A, Caballero‐Fonseca F. NSAID hypersensitivity in the COX‐2 inhibitor era. ACI Int 2001; 13(5)211–217
   Google Scholar
• Szczeklik A. The cyclooxygenase theory of aspirin‐induced asthma. Eur Respir J 1990; 3: 588, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Vigano T, Habib A, Hernandez A, Bonazzi A, Boraschi D, Lebret M, Cassina E, Maclouf J, Sala A, Falco G. Cyclooxygenase‐2 and synthesis of PGE2 in human bronchial smooth‐muscle cells. Am J Respir Crit Care Med 1997; 155: 864, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Szczeklik A, Sanak M. Molecular mechanisms in aspirin‐induced asthma. ACI Int 2000; 12: 171
   Google Scholar
• Çelik G, Bavbek S, Mısırlıgil Z, Melli M. In vitro release of cysteinyl leukotrienes with aspirin stimulation and effect of prostaglandin E2 on this release in aspirin‐sensitive asthmatics. Clin Exp Allergy 2001; 31: 1615, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sladek K, Dworski R, Soja J, Nizankowska E, Oates J A, Szczeklik A. Eicosanoids in bronchoalveolar lavage fluid of aspirin‐intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 154: 1608–1614
   Google Scholar
• Szczeklik A, Stevenson D D. Aspirin‐induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104: 5–13, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Spector S L, Wangaar C H, Farr R S. Aspirin and concomitant idiosyncrasies in adult asthmatic patients. J Allergy Clin Immunol 1979; 64: 500, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Andri L, Senna G, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, Andri G. Tolerability of nimesulide in aspirin‐sensitive patients. Ann Allergy 1994; 72: 29, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Quaratino D, Romano A, Di Fonso M, Papa G, Perrone M R, D'Ambrosio F P, Venuti A. Tolerability of meloxicam in patients with histories of adverse reactions to nonsteroidal anti‐inflammatory drugs. Ann Allergy, Asthma, & Immun 2000; 84: 513
   Google Scholar
• Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Safety of a specific COX‐2 inhibitor in aspirin‐induced asthma. Clin Exp Allergy 2001; 31(2)219, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 1987; 136: 225
   PubMed Web of Science ®Google Scholar
• Papa G, Romano A, Del Bono A, Quaratino D, Di Fonso M, Pocobelli D, Guiffreda F, Venuti A. Floctafenine: a valid alternative in patients with adverse reactions to nonsteroidal anti‐inflammatory drugs. Ann Allergy, Asthma, & Immun 1997; 78: 74
   PubMedGoogle Scholar
• Çelik G, Mungan D, Bavbek S, Demirel Y S, Sin B, Ediger D, Mısırlıgil Z. The prevalence of allergic diseases and atopy in Ankara, Turkey: a two‐step population‐based epidemiological study. J Asthma 1999; 36: 281
   PubMed Web of Science ®Google Scholar
• Ispano M, Fontana A, Scibilia J, Ortolani C. Oral challenge with alternative nonsteroidal anti‐inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drug 1993; 46(suppl. 1)253
   PubMedGoogle Scholar
• Bianco S, Robuschi M, Petrigni G, Scuri M, Pieroni M G, Refini R M, Vaghi A, Sestini P S. Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993; 46(suppl. 1)115, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Vane J R. Aspirin and other anti‐inflammatory drugs. Thorax 2000; 55(suppl. 2)S3–S9, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Bavbek S, Çelik G, Ediger D, Mungan D, Demirel Y S, Msil Z. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti‐inflammatory drug intolerance. J Asthma 1999; 36: 657, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Asero R. Aspirin and paracetamol tolerance in patients with nimesulide‐induced urticaria. Ann Allergy, Asthma, & Immun 1998; 81: 237
   PubMedGoogle Scholar
• Kosnik M, Music E, Matjaz F, Suskovic S. Relative safety of meloxicam in NSAID‐intolerant patients. Allergy 1998; 53: 1231, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ehrich E W, Dalob A, De Lepeleire I, Porras A, Wittreich J, Seibold J R, DeShepper P, Mehlisch D R, Gertz B J. Characterization of rofecoxib as a cyclooxygenase‐2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 1999; 65: 336, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Yoshida S, Ishizaki Y, Onuma K, Shori T, Nakagawa H, Amayasu H. Selective cyclooxygenase inhibition in patients with aspirin‐induced asthma. J Allergy Clin Immunol 2000; 106: 1201–1202, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Gotta A W. Valdecoxib (Pharmacia). Curr Opin Investig Drugs 2002; 3(2)240–524, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Schwartz J I, Chan C C, Mukhopadhyaya S, McBride K J, Jones T M, Adcock S, Moritzz C, Hedges J, Grasing K, Dobratz D, Cohen R A, Davidson M H, Bachmann K A, Gertz B J. Cyclooxygenase‐2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 1999; 65: 653, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Stevenson D D, Simon R A. Lack of cross‐reactivity between rofecoxib and aspirin in aspirin‐sensitive patients with asthma. J Allergy Clin Immunol 2001; 108: 47–51, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Pacor M L, Di Lorenzo G, Biasi M, Barbagallo M, Correchor R. Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non‐steroidal antiinflammatory drugs. Clin Exp Allergy 2002; 32: 397, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stevenson D D, Simon R A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. Allergy, Principles and Practice, E Middleton, C E Reed, E F Ellis, N F Adkinson, J W Yunginger, W W Busse. Mosby‐Year Book, St. Louis 1993; 1747–1765
   Google Scholar
• Stevenson D D. Challenge procedures in detection of reactions to aspirin and nonsteroidal anti‐inflammatory drugs. Ann Allergy 1993; 71: 417, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Asero R. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID‐induced skin disorders. Ann Allergy, Asthma, & Immun 1999; 82: 554
   PubMed Web of Science ®Google Scholar
• Bochenek G, Nizankowska E, Szczeklik A. The atopy trial in hypersensitivity to nonsteroidal anti‐inflammatory drugs. Allergy 1996; 51: 16, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sanchez‐Borges M, Capriles‐Hulett A. Atopy is a risk factor for nonsteroidal anti‐inflammatory drug sensitivity (NSAIDs). Ann Allergy, Asthma, & Immun 2001; 84(1)101
   Google Scholar
• Çelik G, Mungan D, Özer F, Ediger D, Bavbek S, Sin B, Demirel Y S, Mısırlıgil Z. Clinical features and atopy profile in Turkish subjects with analgesic intolerance. J Asthma 2002; 39(2)101, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pastorello E A, Zara C, Riario‐Sforza G G, Pravettoni V, Incorvaria C. Atopy and intolerance of antimicrobial drugs increase the risk of reactions to acetaminophen and nimesulide in patients allergic to nonsteroidal anti‐inflammatory drugs. Allergy 1998; 53: 880, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar